IpiNovyx Bio
Developing multiple series of highly selective, ultra potent small molecule therapeutics for the treatment of autoimmune and inflammatory disorders.
Launch date
Employees
Market cap
-
Enterprise valuation
$40—60m (Dealroom.co estimates Oct 2021.)
Town of Clarkstown New York (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
* | $10.0m | Seed | |
Total Funding | $10.0m |